Effect of Reduced-Dose Capecitabine Plus Cetuximab as Maintenance Therapy for RAS Wild-Type Metastatic Colorectal Cancer: A Phase 2 Clinical Trial

IMPORTANCE: Fluorouracil-based chemotherapy combined with anti–epidermal growth factor receptor/vascular endothelial growth factor therapy is the standard first-line treatment for metastatic colorectal cancer followed by low-intensity maintenance therapy to balance the clinical efficacy and adverse...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Lu, Liu, Ying, Yin, Xianli, Fang, Weijia, Xiong, Jianping, Zhao, Ben, Zhang, Mingsheng, Zou, Yanmei, Qiu, Hong, Yuan, Xianglin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Medical Association 2020
Materias:
Original Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7372324/
https://www.ncbi.nlm.nih.gov/pubmed/32687588
http://dx.doi.org/10.1001/jamanetworkopen.2020.11036

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7372324/
https://www.ncbi.nlm.nih.gov/pubmed/32687588
http://dx.doi.org/10.1001/jamanetworkopen.2020.11036

Ejemplares similares